<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35304834</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2055-5822</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>9</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>ESC heart failure</Title>
          <ISOAbbreviation>ESC Heart Fail</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Long non-coding RNA Sox2OT promotes coronary microembolization-induced myocardial injury by mediating pyroptosis.</ArticleTitle>
        <Pagination>
          <StartPage>1689</StartPage>
          <EndPage>1702</EndPage>
          <MedlinePgn>1689-1702</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/ehf2.13814</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">As a common complication of coronary microembolization (CME), myocardial injury (MI) implies high mortality. Long non-coding RNAs (lncRNAs) are rarely studied in CME-induced MI. Herein, this study intended to evaluate the role of lncRNA Sox2 overlapping transcript (Sox2OT) in CME-induced MI.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">The CME rat models were successfully established by injection of microemboli. Rat cardiac functions and MI were observed by ultrasonic electrocardiogram, HE staining, and HBFP staining. Functional assays were utilized to test the inflammatory responses, oxidative stress, and pyroptosis using reverse transcription quantitative polymerase chain reaction, Western blotting, immunohistochemistry, immunofluorescence, and ELISA. Dual-luciferase reporter gene assay and RNA immunoprecipitation were conducted to clarify the targeting relations between Sox2OT and microRNA (miRNA)-23b and between miR-23b and toll-like receptor 4 (TLR4).</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Rat CME disrupted the cardiac functions and induced inflammatory responses and oxidative stress, and activated the nuclear factor-kappa B (NF-κB) pathway and pyroptosis (all P &lt; 0.05). An NF-κB inhibitor downregulated the NF-κB pathway, reduced pyroptosis, and relieved cardiomyocyte injury and pyroptosis. Compared with the sham group (1.05 ± 0.32), lncRNA Sox2OT level (4.41 ± 0.67) in the CME group was elevated (P &lt; 0.05). Sox2OT acted as a competitive endogenous RNA (ceRNA) of miR-23b to regulate TLR4. Silencing of Sox2OT favoured miR-23b binding to 3'UTR of TLR4 mRNA leading to suppressed TLR4-mediated NFKB signalling and pyroptosis in myocardial tissues harvested from CME rat models. In addition, miR-23b overexpression could supplement the cytosolic miR-23b reserves to target TLR-4 and partially reverse Sox2OT-mediated pyroptosis in LPS-treated H9C2 cells.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study supported that silencing Sox2OT inhibited CME-induced MI by eliminating Sox2OT/miR-23b binding and down-regulating the TLR4/NF-κB pathway. This investigation may provide novel insights for the treatment of CME-induced MI.</AbstractText>
          <CopyrightInformation>© 2022 The Authors. ESC Heart Failure published by John Wiley &amp; Sons Ltd on behalf of European Society of Cardiology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xuan</LastName>
            <ForeName>Liying</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities, No. 1742 Holin River Street, Tongliao, Inner Mongolia, 028002, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Inner Mongolia Key Laboratory, Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fu</LastName>
            <ForeName>Danni</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities, No. 1742 Holin River Street, Tongliao, Inner Mongolia, 028002, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Inner Mongolia Key Laboratory, Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhen</LastName>
            <ForeName>Dong</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities, No. 1742 Holin River Street, Tongliao, Inner Mongolia, 028002, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Inner Mongolia Key Laboratory, Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bai</LastName>
            <ForeName>Dongsong</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities, No. 1742 Holin River Street, Tongliao, Inner Mongolia, 028002, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Inner Mongolia Key Laboratory, Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Lijun</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities, No. 1742 Holin River Street, Tongliao, Inner Mongolia, 028002, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Inner Mongolia Key Laboratory, Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gong</LastName>
            <ForeName>Guohua</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0002-1096-8600</Identifier>
            <AffiliationInfo>
              <Affiliation>Medicinal Chemistry and Pharmacology Institute, Inner Mongolia University for Nationalities, No. 1742 Holin River Street, Tongliao, Inner Mongolia, 028002, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Inner Mongolia Key Laboratory, Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System, Tongliao, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>First Medical Clinic, Inner Mongolia University for Nationalities, Tongliao, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>ESC Heart Fail</MedlineTA>
        <NlmUniqueID>101669191</NlmUniqueID>
        <ISSNLinking>2055-5822</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D062085">RNA, Long Noncoding</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069292" MajorTopicYN="N">Pyroptosis</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062085" MajorTopicYN="Y">RNA, Long Noncoding</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051197" MajorTopicYN="N">Toll-Like Receptor 4</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Competitive endogenous RNA</Keyword>
        <Keyword MajorTopicYN="N">Coronary microembolization</Keyword>
        <Keyword MajorTopicYN="N">Long non-coding RNA Sox2 overlapping transcript</Keyword>
        <Keyword MajorTopicYN="N">Myocardial injury</Keyword>
        <Keyword MajorTopicYN="N">NF-κB</Keyword>
        <Keyword MajorTopicYN="N">Pyroptosis</Keyword>
        <Keyword MajorTopicYN="N">TLR4</Keyword>
        <Keyword MajorTopicYN="N">microRNA-23b</Keyword>
      </KeywordList>
      <CoiStatement>The authors declared that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>19</Day>
          <Hour>5</Hour>
          <Minute>34</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35304834</ArticleId>
        <ArticleId IdType="pmc">PMC9065873</ArticleId>
        <ArticleId IdType="doi">10.1002/ehf2.13814</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Kong B, Qin Z, Ye Z, Yang X, Li L, Su Q. microRNA‐26a‐5p affects myocardial injury induced by coronary microembolization by modulating HMGA1. J Cell Biochem
2019; 120: 10756–10766.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30652345</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Heusch G, Skyschally A, Kleinbongard P. Coronary microembolization and microvascular dysfunction. Int J Cardiol
2018; 258: 17–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29429637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Su Q, Lv X, Ye Z. Ligustrazine attenuates myocardial injury induced by coronary microembolization in rats by activating the PI3K/Akt pathway. Oxid Med Cell Longev
2019; 2019: 6791457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6525935</ArticleId>
            <ArticleId IdType="pubmed">31191802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mao Q, Liang X, Wu Y, Lu Y. Nobiletin protects against myocardial injury and myocardial apoptosis following coronary microembolization via activating PI3K/Akt pathway in rats. Naunyn Schmiedebergs Arch Pharmacol
2019; 392: 1121–1130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31073648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Jia C, Chen H, Zhang J, Zhou K, Zhuge Y, Niu C, Qiu J, Rong X, Shi Z, Xiao J, Shi Y, Chu M. Role of pyroptosis in cardiovascular diseases. Int Immunopharmacol
2019; 67: 311–318.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30572256</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Langhorn R, Willesen JL. Cardiac troponins in dogs and cats. J Vet Intern Med
2016; 30: 36–50.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4913658</ArticleId>
            <ArticleId IdType="pubmed">26681537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Guo ZH, You ZH, Wang YB, Yi HC, Chen ZH. A learning‐based method for LncRNA‐disease association identification combing similarity information and rotation Forest. iScience
2019; 19: 786–795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6733997</ArticleId>
            <ArticleId IdType="pubmed">31494494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pant T, Dhanasekaran A, Fang J, Bai X, Bosnjak ZJ, Liang M, Ge ZD. Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy. BMC Cardiovasc Disord
2018; 18: 197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6196023</ArticleId>
            <ArticleId IdType="pubmed">30342478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shen S, Jiang H, Bei Y, Xiao J, Li X. Long non‐coding RNAs in cardiac remodeling. Cell Physiol Biochem
2017; 41: 1830–1837.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28376483</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Greco S, Zaccagnini G, Perfetti A, Fuschi P, Valaperta R, Voellenkle C, Castelvecchio S, Gaetano C, Finato N, Beltrami AP, Menicanti L, Martelli F. Long noncoding RNA dysregulation in ischemic heart failure. J Transl Med
2016; 14: 183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4912721</ArticleId>
            <ArticleId IdType="pubmed">27317124</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen M, Guan Y, Li A, Zhao YZ, Zhang L, Zhang L, Gong Y. LncRNA SOX2OT mediates mitochondrial dysfunction in septic cardiomyopathy. DNA Cell Biol
2019; 38: 1197–1206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31618067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li Z, Jiang P, Li J, Peng M, Zhao X, Zhang X, Chen K, Zhang Y, Liu H, Gan L, Bi H, Zhen P, Zhu J, Li X. Tumor‐derived exosomal lnc‐Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma. Oncogene
2018; 37: 3822–3838.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29643475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ma L, Sun X, Kuai W, Hu J, Yuan Y, Feng W, Lu X. LncRNA SOX2 overlapping transcript acts as a miRNA sponge to promote the proliferation and invasion of Ewing's sarcoma. Am J Transl Res
2019; 11: 3841–3849.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6614621</ArticleId>
            <ArticleId IdType="pubmed">31312393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview. Methods Mol Biol
2017; 1509: 1–10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27826912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Moghaddam AS, Afshari JT, Esmaeili SA, Saburi E, Joneidi Z, Momtazi‐Borojeni AA. Cardioprotective microRNAs: lessons from stem cell‐derived exosomal microRNAs to treat cardiovascular disease. Atherosclerosis
2019; 285: 1–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30939341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Sucharov CC, Kao DP, Port JD, Karimpour‐Fard A, Quaife RA, Minobe W, Nunley K, Lowes BD, Gilbert EM, Bristow MR. Myocardial microRNAs associated with reverse remodeling in human heart failure. JCI Insight
2017; 2: e89169.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5256135</ArticleId>
            <ArticleId IdType="pubmed">28138556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen Z, Li C, Lin K, Zhang Q, Chen Y, Rao L. MicroRNAs in acute myocardial infarction: evident value as novel biomarkers?
Anatol J Cardiol
2018; 19: 140–147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5864810</ArticleId>
            <ArticleId IdType="pubmed">29424735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li L, Li DH, Qu N, Wen WM, Huang WQ. The role of ERK1/2 signaling pathway in coronary microembolization‐induced rat myocardial inflammation and injury. Cardiology
2010; 117: 207–215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21150201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Su Q, Li L, Sun Y, Yang H, Ye Z, Zhao J. Effects of the TLR4/Myd88/NF‐κB signaling pathway on NLRP3 inflammasome in coronary microembolization‐induced myocardial injury. Cell Physiol Biochem
2018; 47: 1497–1508.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29940584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yang F, Luo L, Zhu ZD, Zhou X, Wang Y, Xue J, Zhang J, Cai X, Chen ZL, Ma Q, Chen YF, Wang YJ, Luo YY, Liu P, Zhao L. Chlorogenic acid inhibits liver fibrosis by blocking the miR‐21‐regulated TGF‐beta1/Smad7 signaling pathway in vitro and in vivo. Front Pharmacol
2017; 8: 929.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5742161</ArticleId>
            <ArticleId IdType="pubmed">29311932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Teng JF, Mei QB, Zhou XG, Tang Y, Xiong R, Qiu WQ, Pan R, Law BY, Wong VK, Yu CL, Long H‐A, Xiao X‐L, Zhang F, Wu J‐M, Qin D‐L, Wu A‐G. Polyphyllin VI induces caspase‐1‐mediated pyroptosis via the induction of ROS/NF‐κB/NLRP3/GSDMD signal axis in non‐small cell lung cancer. Cancers (Basel)
2020; 12: 193.</Citation>
        </Reference>
        <Reference>
          <Citation>
Li CP, Wang SH, Wang WQ, Song SG, Liu XM. Long noncoding RNA‐Sox2OT knockdown alleviates diabetes mellitus‐induced retinal ganglion cell (RGC) injury. Cell Mol Neurobiol
2017; 37: 361–369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27193103</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Weinmann L, Hock J, Ivacevic T, Ohrt T, Mutze J, Schwille P, Kremmer E, Benes V, Urlaub H, Meister G. Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs. Cell
2009; 136: 496–507.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19167051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Liu T, Zhou Y, Wang JY, Su Q, Tang ZL, Liu YC, Li L. Coronary microembolization induces cardiomyocyte apoptosis in swine by activating the LOX‐1‐dependent mitochondrial pathway and Caspase‐8‐dependent pathway. J Cardiovasc Pharmacol Ther
2016; 21: 209–218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26275408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li S, Fang J, Chen L. Pyrrolidine dithiocarbamate attenuates cardiocyte apoptosis and ameliorates heart failure following coronary microembolization in rats. Balkan Med J
2019; 36: 245–250.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6636647</ArticleId>
            <ArticleId IdType="pubmed">31140237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Liu Z, Gan L, Xu Y, Luo D, Ren Q, Wu S, Sun C. Melatonin alleviates inflammasome‐induced pyroptosis through inhibiting NF‐κB/GSDMD signal in mice adipose tissue. J Pineal Res
2017; 63: e12414.</Citation>
        </Reference>
        <Reference>
          <Citation>
Toldo S, Mauro AG, Cutter Z, Abbate A. Inflammasome, pyroptosis, and cytokines in myocardial ischemia‐reperfusion injury. Am J Physiol Heart Circ Physiol
2018; 315: H1553–H1568.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6336966</ArticleId>
            <ArticleId IdType="pubmed">30168729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wu H, Liu J, Li W, Liu G, Li Z. LncRNA‐HOTAIR promotes TNF‐alpha production in cardiomyocytes of LPS‐induced sepsis mice by activating NF‐κB pathway. Biochem Biophys Res Commun
2016; 471: 240–246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26806307</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shahryari A, Jazi MS, Samaei NM, Mowla SJ. Long non‐coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis. Front Genet
2015; 6: 196.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4469893</ArticleId>
            <ArticleId IdType="pubmed">26136768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell
2005; 122: 947–956.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3006442</ArticleId>
            <ArticleId IdType="pubmed">16153702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Mandalos N, Rhinn M, Granchi Z, Karampelas I, Mitsiadis T, Economides AN, Dolle P, Remboutsika E. Sox2 acts as a rheostat of epithelial to mesenchymal transition during neural crest development. Front Physiol
2014; 5: 345.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4162359</ArticleId>
            <ArticleId IdType="pubmed">25309446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Fu FY, Chen BY, Chen LL, Zhang FL, Luo YK, Jun F. Improvement of the survival and therapeutic effects of implanted mesenchymal stem cells in a rat model of coronary microembolization by rosuvastatin treatment. Eur Rev Med Pharmacol Sci
2016; 20: 2368–2381.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27338064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Suzuki G, Young RF, Leiker MM, Suzuki T. Heart‐derived stem cells in miniature swine with coronary microembolization: novel ischemic cardiomyopathy model to assess the efficacy of cell‐based therapy. Stem Cells Int
2016; 2016: 6940195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5055979</ArticleId>
            <ArticleId IdType="pubmed">27738436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Schwach V, Gomes Fernandes M, Maas S, Gerhardt S, Tsonaka R, van der Weerd L, Passier R, Mummery CL, Birket MJ, Salvatori DCF. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction. Cardiovasc Res
2020; 116: 545–553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7252440</ArticleId>
            <ArticleId IdType="pubmed">31287499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang Y, Wu N, Luo X, Zhang X, Liao Q, Wang J. SOX2OT, a novel tumor‐related long non‐coding RNA. Biomed Pharmacother
2020; 123: 109725.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31865145</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cao C, Zhang Y, Chai Y, Wang L, Yin C, Shou S, Jin H. Attenuation of sepsis‐induced cardiomyopathy by regulation of MicroRNA‐23b is mediated through targeting of MyD88‐mediated NF‐κB activation. Inflammation
2019; 42: 973–986.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30734878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Boon RA, Jae N, Holdt L, Dimmeler S. Long noncoding RNAs: from clinical genetics to therapeutic targets?
J Am Coll Cardiol
2016; 67: 1214–1226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26965544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cui B, Liu W, Wang X, Chen Y, Du Q, Zhao X, Zhang H, Liu SL, Tong D, Huang Y. Brucella Omp25 upregulates miR‐155, miR‐21‐5p, and miR‐23b to inhibit Interleukin‐12 production via modulation of programmed Death‐1 signaling in human monocyte/macrophages. Front Immunol
2017; 8: 708.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5483987</ArticleId>
            <ArticleId IdType="pubmed">28694807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li H, Han X, Zuo K, Li L, Liu J, Yuan X, Shen Y, Shao M, Pang D, Chu Y, Zhao B. miR‐23b promotes cutaneous wound healing through inhibition of the inflammatory responses by targeting ASK1. Acta Biochim Biophys Sin (Shanghai)
2018; 50: 1104–1113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30188966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Du Y, Gu X, Meng H, Aa N, Liu S, Peng C, Ge Y, Yang Z. Muscone improves cardiac function in mice after myocardial infarction by alleviating cardiac macrophage‐mediated chronic inflammation through inhibition of NF‐κB and NLRP3 inflammasome. Am J Transl Res
2018; 10: 4235–4246.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6325512</ArticleId>
            <ArticleId IdType="pubmed">30662666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lei Q, Yi T, Chen C. NF‐κB‐Gasdermin D (GSDMD) Axis couples oxidative stress and NACHT, LRR and PYD domains‐containing protein 3 (NLRP3) Inflammasome‐mediated cardiomyocyte Pyroptosis following myocardial infarction. Med Sci Monit
2018; 24: 6044–6052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6128186</ArticleId>
            <ArticleId IdType="pubmed">30161099</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
